ibudilast development codes antiinflammatory drug used mainly japan acts phosphodiesterase inhibitor inhibiting subtype greatest also showing significant inhibition pde japan ibudilast oral capsules approved treatment asthma improvement dizziness secondary chronic cerebral circulation impairment associated sequelae cerebral ibudilast ophthalmic solution indicated treatment allergic conjunctivitis hay may use reducing addiction ibudilast bronchodilator neuroprotective mainly used treatment asthma inhibits platelet may also useful treatment multiple ibudilast crosses barrier suppresses glial cell activation activity shown make ibudilast useful treatment neuropathic pain enhances analgesia produced opioid drugs also reduces development ibudilast principally inhibitor also shown act antagonist tolllike receptor likely plays large part effect specifically synergy opioid drugs antiinflammatory effect painkilling unknown properties potentiate effects inactivation andor vice versa despite effects shared inflammation reducing antagonists theoretically reverse increase pain inflammation caused agonists includes alcohol many opiate opioid httpsenwikipediaorgwikiibudilast